In silico combinatorial therapy ranking

Having a genome-scale metabolic model it becomes possible to look for drugs or their combinations that disable metabolic strategies of ill tissues having less harm to healthy tissues.

Drug combinations can be ranked according to a multifactorial criterion affected by factors like 1) number of drugs in the combination, 2) expected toxicity, 3) costs and other relevant parameters depending on the application.